These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12843567)

  • 1. [Amyloid-beta peptide metabolism and Alzheimer's disease].
    Iwata N; Saido TC
    Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):5-14. PubMed ID: 12843567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of amyloid-beta peptide and Alzheimer's disease.
    Iwata N; Higuchi M; Saido TC
    Pharmacol Ther; 2005 Nov; 108(2):129-48. PubMed ID: 16112736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology.
    Fukami S; Watanabe K; Iwata N; Haraoka J; Lu B; Gerard NP; Gerard C; Fraser P; Westaway D; St George-Hyslop P; Saido TC
    Neurosci Res; 2002 May; 43(1):39-56. PubMed ID: 12074840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease, neuropeptides, neuropeptidase, and amyloid-beta peptide metabolism.
    Saito T; Takaki Y; Iwata N; Trojanowski J; Saido TC
    Sci Aging Knowledge Environ; 2003 Jan; 2003(3):PE1. PubMed ID: 12844556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
    Higuchi M; Iwata N; Saido TC
    Biochim Biophys Acta; 2005 Aug; 1751(1):60-7. PubMed ID: 16054018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic regulation of brain Abeta by neprilysin.
    Iwata N; Tsubuki S; Takaki Y; Shirotani K; Lu B; Gerard NP; Gerard C; Hama E; Lee HJ; Saido TC
    Science; 2001 May; 292(5521):1550-2. PubMed ID: 11375493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene therapy for Alzheimer' s disease].
    Iwata N; Ozawa K; Saido TC
    Nihon Rinsho; 2005 Mar; 63(3):394-400. PubMed ID: 15773336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nobiletin Reduces Intracellular and Extracellular β-Amyloid in iPS Cell-Derived Alzheimer's Disease Model Neurons.
    Kimura J; Shimizu K; Kajima K; Yokosuka A; Mimaki Y; Oku N; Ohizumi Y
    Biol Pharm Bull; 2018; 41(4):451-457. PubMed ID: 29607920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging.
    Iwata N; Takaki Y; Fukami S; Tsubuki S; Saido TC
    J Neurosci Res; 2002 Nov; 70(3):493-500. PubMed ID: 12391610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
    Devi L; Ohno M
    Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease.
    Guan H; Liu Y; Daily A; Police S; Kim MH; Oddo S; LaFerla FM; Pauly JR; Murphy MP; Hersh LB
    J Neurosci Res; 2009 May; 87(6):1462-73. PubMed ID: 19021293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons.
    Hama E; Shirotani K; Masumoto H; Sekine-Aizawa Y; Aizawa H; Saido TC
    J Biochem; 2001 Dec; 130(6):721-6. PubMed ID: 11726269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts.
    Kawakubo T; Mori R; Shirotani K; Iwata N; Asai M
    Biol Pharm Bull; 2017; 40(3):327-333. PubMed ID: 28250274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide.
    Hama E; Saido TC
    Med Hypotheses; 2005; 65(3):498-500. PubMed ID: 15921860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major amyloid-β-degrading enzymes, endothelin-converting enzyme-2 and neprilysin, are expressed by distinct populations of GABAergic interneurons in hippocampus and neocortex.
    Pacheco-Quinto J; Eckman CB; Eckman EA
    Neurobiol Aging; 2016 Dec; 48():83-92. PubMed ID: 27644077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neprilysin regulates amyloid Beta peptide levels.
    Marr RA; Guan H; Rockenstein E; Kindy M; Gage FH; Verma I; Masliah E; Hersh LB
    J Mol Neurosci; 2004; 22(1-2):5-11. PubMed ID: 14742905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. γ-Hydroxybutyrate (Xyrem) ameliorates clinical symptoms and neuropathology in a mouse model of Alzheimer's disease.
    Klein C; Mathis C; Leva G; Patte-Mensah C; Cassel JC; Maitre M; Mensah-Nyagan AG
    Neurobiol Aging; 2015 Feb; 36(2):832-44. PubMed ID: 25457559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.